Phibro Animal Health reported $400.62M in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Aurora Cannabis Inc ACB:CN 343.55M 26.3M
Bristol Myers Squibb BMY:US $ 37107M 343M
Canopy Growth Corp WEED:CN C$ 1.26B 270.14M
Corcept Therapeutics CORT:US $ 0M 0M
Depomed DEPO:US $ 49.5M 11.75M
Eli Lilly And LLY:US $ 14692M 460.9M
Henry Schein HSIC:US $ 769M 4M
Idexx Laboratories IDXX:US $ 768M 5.39M
JAZZ PHA JAZZ:US $ 5990M 2.87M
Knight Therapeutics Inc GUD:CN C$ 13.97M 1.29M
Lannett LCI:US $ 610.08M 6.6M
Nektar Therapeutics NKTR:US $ 0M 0M
Pacira Pharmaceuticals PCRX:US $ 721.88M 7.86M
Phibro Animal Health PAHC:US $ 400.62M 13.3M
Prestige Brands PBH:US $ 1476.23M 4.93M
Supernus Pharmaceuticals SUPN:US $ 0M 400.38M
Teva Pharmaceutical Industries TEVA:US $ 20363M 477M
Zoetis ZTS:US $ 5221M 7M